GlaxoSmithKline | GSK - Zapasy





Zapasy Zmiana Data
AbbVie USD 5.05B 98M 2026-03
Alcon AG USD 2.44B 47M 2026-03
Almirall EUR 178.13M 1.54M 2025-12
Amgen USD 6.19B 39M 2026-03
argenx SE USD 473.53M 132.91M 2025-12
AstraZeneca USD 6.57B 13M 2026-03
Bayer EUR 12.34B 3M 2025-12
Biogen USD 1.95B 219.1M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Fresenius EUR 2.61B 19M 2025-12
Fresenius Medical Care EUR 2.3B 162.24M 2026-03
Genmab DKK 13M 1000K 2025-06
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.12B 46M 2025-09
GRIFOLS EUR 3.35B 213.23M 2025-06
Hikma Pharmaceutical USD 1.08B 96M 2025-06
Lakefront Biotherapeutics EUR 17.69M 4.8M 2026-03
Lonza CHF 1.68B 163M 2025-12
Merck EUR 4.56B 52M 2025-12
Merck USD 6.48B 179M 2026-03
Novartis USD 6.29B 17M 2026-03
Novo Nordisk DKK 45.65B 21.26B 2025-06
Orion EUR 456.3M 12.6M 2025-12
Pfizer USD 10.67B 13M 2026-03
Philips EUR 2.87B 390M 2025-12
Recordati EUR 539.8M 34.61M 2025-12
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
UCB EUR 1.31B 173M 2024-12